These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Aβ40. Yan LM; Velkova A; Tatarek-Nossol M; Rammes G; Sibaev A; Andreetto E; Kracklauer M; Bakou M; Malideli E; Göke B; Schirra J; Storr M; Kapurniotu A Angew Chem Int Ed Engl; 2013 Sep; 52(39):10378-83. PubMed ID: 23956012 [No Abstract] [Full Text] [Related]
3. Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process. Wahlström A; Cukalevski R; Danielsson J; Jarvet J; Onagi H; Rebek J; Linse S; Gräslund A Biochemistry; 2012 May; 51(21):4280-9. PubMed ID: 22554145 [TBL] [Abstract][Full Text] [Related]
4. Substituted tryptophans at amyloid-β(1-40) residues 19 and 20 experience different environments after fibril formation. McDonough RT; Paranjape G; Gallazzi F; Nichols MR Arch Biochem Biophys; 2011 Oct; 514(1-2):27-32. PubMed ID: 21843498 [TBL] [Abstract][Full Text] [Related]
5. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation. Takahashi T; Mihara H Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of sugar-based peptidomimetics as modulators of amyloid β-peptide early oligomerization and fibrillization. Kaffy J; Brinet D; Soulier JL; Khemtémourian L; Lequin O; Taverna M; Crousse B; Ongeri S Eur J Med Chem; 2014 Oct; 86():752-8. PubMed ID: 25238173 [TBL] [Abstract][Full Text] [Related]
7. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579 [TBL] [Abstract][Full Text] [Related]
8. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease? Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267 [TBL] [Abstract][Full Text] [Related]
9. Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease. Goyal D; Shuaib S; Mann S; Goyal B ACS Comb Sci; 2017 Feb; 19(2):55-80. PubMed ID: 28045249 [TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663 [TBL] [Abstract][Full Text] [Related]
11. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. Milojevic J; Esposito V; Das R; Melacini G J Am Chem Soc; 2007 Apr; 129(14):4282-90. PubMed ID: 17367135 [TBL] [Abstract][Full Text] [Related]
13. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes. Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646 [TBL] [Abstract][Full Text] [Related]
14. Dissecting the role of single regions of an IAPP mimic and IAPP in inhibition of Aβ40 amyloid formation and cytotoxicity. Andreetto E; Yan LM; Caporale A; Kapurniotu A Chembiochem; 2011 Jun; 12(9):1313-22. PubMed ID: 21630409 [TBL] [Abstract][Full Text] [Related]
15. Key aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction Bakou M; Hille K; Kracklauer M; Spanopoulou A; Frost CV; Malideli E; Yan LM; Caporale A; Zacharias M; Kapurniotu A J Biol Chem; 2017 Sep; 292(35):14587-14602. PubMed ID: 28684415 [TBL] [Abstract][Full Text] [Related]
16. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease. Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062 [TBL] [Abstract][Full Text] [Related]
17. In vitro amyloid-β binding and inhibition of amyloid-β self-association by therapeutic albumin. Milojevic J; Costa M; Ortiz AM; Jorquera JI; Melacini G J Alzheimers Dis; 2014; 38(4):753-65. PubMed ID: 24072068 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro. Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336 [TBL] [Abstract][Full Text] [Related]
19. A carboxylated Zn-phthalocyanine inhibits fibril formation of Alzheimer's amyloid β peptide. Tabassum S; Sheikh AM; Yano S; Ikeue T; Handa M; Nagai A FEBS J; 2015 Feb; 282(3):463-76. PubMed ID: 25404240 [TBL] [Abstract][Full Text] [Related]
20. Protective effect of ε-viniferin on β-amyloid peptide aggregation investigated by electrospray ionization mass spectrometry. Richard T; Poupard P; Nassra M; Papastamoulis Y; Iglésias ML; Krisa S; Waffo-Teguo P; Mérillon JM; Monti JP Bioorg Med Chem; 2011 May; 19(10):3152-5. PubMed ID: 21524590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]